Latest Distribution Agreements News

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.

Merino & Co. Limited has unveiled a robust growth plan at its 2025 AGM, highlighting strengthened finances, operational expansion, and a clear focus on sustainability and premium brand positioning in the global apparel market.

MNC reports a strong FY25 marked by operational expansion and financial strengthening, setting the stage for disciplined international growth and premium brand elevation.

Algorae Pharmaceuticals has secured a key distribution agreement with global giant Dr. Reddy’s Laboratories to supply the chemotherapy drug Capecitabine in Australia, marking a significant step in its oncology commercialisation strategy.

Accent Group reports modest sales growth but margin pressures in FY26 H1, announces MySale closure and new Sports Direct store launch.

OMG Group has secured its maiden purchase order for premium SANDAI matcha in Australia, marking a promising start to a new high-margin revenue channel ahead of FY26.

HITIQ Limited has launched its PROTEQT™ concussion management system in North America, securing exclusive Canadian distribution rights and initiating a dual-channel market strategy targeting hockey’s vast ecosystem.

OMG Group has inked a five-year exclusive distribution agreement with SANDAI, a premium Japanese matcha producer, positioning itself to capture significant growth in Australia’s expanding matcha market.

Merino & Co. has secured a significant distribution agreement with a Shanghai-based omni-channel partner, committing to annual sales of approximately A$1.5 million and expanding its footprint in China’s luxury fashion market.

Zeotech Limited has signed a non-binding Letter of Intent with Bisley & Company to explore marketing and distribution of its high-reactivity metakaolin product, AusPozz™, across Australia and key international markets.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.